I

IO Biotech
D

IOBT

0.73000
USD
0.03
(3.99%)
Pre Open
Volume
20
EPS
-1
Div Yield
-
P/E
-1
Market Cap
48,093,067
News

Title: IO Biotech

Sector: Healthcare
Industry: Biotechnology
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.